Prolonged QTc Interval and Sudden Cardiac Death in Older Adults  by Lehmann, Michael H.
percentage of patients who failed to achieve the target heart
rate in our study can be termed as exceptionally high. In the
study by Calnon et al. (2), which evaluated dobutamine stress
imaging in a population similar to ours, the median peak
percentage heart rate achieved was only 81%. Thus, more than
50% of patients did not achieve 85% of maximum predicted
heart rate.
4. Although it is true that the survival curves in our study tended
to be steeper during late follow-up, the number of patients
who had follow-up of more than four years was very small (90
or less, in comparison to 1,205 at the beginning of follow-up).
Thus, we do not agree that the longer follow-up contributed to
the higher annual event rate in the study population. We have
recalculated event rates with only two years of follow-up in our
data: the annualized event rate for patients with normal
perfusion and function was still 2.2%, with the median time to
event being 14 months. Further, in the previous study by
Calnon et al. (2) (which also examined a similar high-risk
population) the mean follow-up was approximately two years;
the annualized event rates were also higher. Finally, Vanzetto
et al. (7) reported on long-term follow-up of patients under-
going exercise stress imaging. After a mean follow-up of 72
months, the cardiac event rate in patients with normal
thallium-201 single-photon emission computed tomography
was 0.56%, indicating that the prognostic value of normal
exercise stress imaging is maintained over a substantial period
of time.
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Prolonged QTc Interval and
Sudden Cardiac Death in Older Adults
With considerable interest I read the recent study by Straus et al.
(1) reporting QTc prolongation (450 ms in men, and 470 ms
in women) as an independent predictor of sudden cardiac death
(SCD) in the large population-based Rotterdam study cohort of
older adults (aged 55 years). Although various clinical and
epidemiologic risk factors—including hypertension, myocardial
infarction, heart failure, and diabetes—were incorporated into
their multivariable model for calculating hazard ratios, the inves-
tigators did not include several important electrocardiographic
(ECG) parameters that may be informative regarding susceptibil-
ity to SCD, QT prolongation, or both.
Chief among these are QRS voltage and ST-T criteria for left
ventricular hypertrophy (LVH). Even after statistically adjusting
for hypertension, LVH is a known risk factor for cardiac mortality,
and specifically SCD (2,3); LVH also causes electrophysiologic
remodeling that results in prolongation of action potential duration
and the QT interval (4). These alterations, together with concom-
itant conduction delays—which, macroscopically, may manifest
with various degrees of QRS prolongation (relative or absolute)—
set the stage for ventricular tachyarrhythmogenesis and SCD. An
ST-T “strain” pattern in the setting of ECG–LVH confers
increased risk of heart failure (5), which in turn may predispose to
SCD, in part through prolonged repolarization (6). Of course,
ST-segment depression and “nonspecific” or “minor” ST-T abnor-
malities may also be indications of subclinical coronary atheroscle-
rosis (7,8), another risk factor for SCD.
A previous study of the Rotterdam cohort by Kors et al. (9)
demonstrated that an abnormal T-wave axis (i.e., falling between
either 15° and 180°, or 105° and 180°) was a statistically
significant predictor of SCD (hazard ratio 3.1 [95% confidence
interval, 1.7 to 5.5], after adjustment for age, gender, and cardio-
vascular risk factors). Moreover, using a statistical model in which
prolonged QTc, abnormal T axis, and other relevant ECG
abnormalities (as previously noted) were entered simultaneously,
Kors et al. (9) found that abnormal T axis—but not prolonged
QTc—was an independent predictor of cardiac death (44% of
which cases were sudden).
Also omitted from the statistical analysis of Straus et al. (1) were
2 predictors of prolonged rate-corrected QT (10), namely QRS
duration (which can be relatively longer [not necessarily 120 ms]
in settings of LVH or myocardial fibrosis) and use of class IA
antiarrhythmic drug (in vogue during the Rotterdam study period).
Given the potential mechanistic, epidemiologic, and clinical
implications of the investigators’ study, until their multivariable
model is expanded to include the established (and biologically
plausible) covariates discussed above, it is probably premature to
conclude that prolonged QTc is a statistically independent predic-
tor of SCD in older adults.
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REPLY
We would like to thank Professor Lehmann for his valuable
comments in which he raises 3 points. First, we agree that left
ventricular hypertrophy (LVH) and its increased risk of heart
failure, as well as coronary atherosclerosis, are important risk
factors for sudden cardiac death (SCD). Therefore, we adjusted
our analyses for incident heart failure and for several measures of
atherosclerosis. These variables were not available in the earlier
analyses with baseline information from the Rotterdam Study, but
in the current analyses we were able to adjust for this follow-up
information.
Second, in earlier studies we reported on the prognostic value of
an abnormal T-wave axis (1). In these analyses, QTc prolongation
was not an independent risk factor, but this was probably due to a
lack of sample size and to the fact that we now used SCD as an end
point instead of sudden death and all cardiac death. Moreover, we
used other cut-off points for QTc prolongation than in our earlier
study. Because of the substantial interest of regulatory bodies for
the potential role of QTc prolongation and because of the
widespread clinical use of the QTc interval (whereas the frontal T
axis is uncommonly used in clinical practice), we focused our
current analyses on this ECG feature.
In a model containing the QTc interval, T-wave axis, LVH on
the electrocardiogram, age, and gender, an abnormal frontal
T-wave axis (between 15° and 180° or between 105° and 180°)
showed a strongly increased risk of SCD (hazard ratio [HR] 2.84
[95% confidence interval {CI} 1.37 to 5.90]), but the HR of QTc
prolongation was still 3.16 (95% CI 1.69 to 5.89). In the fully
adjusted model, this HR hardly changed. Additional adjustment
for QRS duration (120 ms) resulted in an HR of QTc prolon-
gation for SCD of 2.97 (95% CI 1.51 to 5.83).
Third, antiarrhythmic drugs may increase the QTc interval, but
as they then precede the association between QTc interval and SCD
they should not be adjusted for. We conclude that QTc prolongation
in our study was an independent risk factor for SCD (2).
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